Physician profile
Michael L Smith
NPI 1790881373
$3,960.74
in general payments reported to CMS, 2019-2025
18 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $501 · 2021: $550 · 2022: $713 · 2023: $684 · 2024: $339 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,464.42 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Acuity Steerable |
| Edwards Lifesciences Corporation | $819.88 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic Vascular, INC. | $423.33 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $301.42 | 2020-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $235.00 | 2021-2024 | Linq II |
| Pfizer INC. | $125.36 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $115.78 | 2020-2024 | Xarelto |
| Abiomed | $111.57 | 2022 | |
| Cleerly, INC. | $59.58 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Baxter Healthcare | $52.44 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $50.67 | 2021-2023 | Verquvo |
| Abbott Laboratories | $50.61 | 2023 | Diamondback Peripheral |
| Amarin Pharma, INC. | $37.26 | 2020-2022 | |
| Cardiva Medical, INC. | $35.33 | 2023 | Cardiva Vascade 6/7f Vcs |
| Novartis Pharmaceuticals Corporation | $28.97 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $28.90 | 2023 | |
| Cashflow Solutions, LLC | $13.29 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.93 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.